March 2023
1. CASTEDAL M, Schult A, Kotopouli MI, Bottai M, et al
   Alcohol as a risk factor for mortality in liver transplant patients in Sweden.
   Scand J Gastroenterol. 2023;58:269-275.
   

   >> Share

   
   September 2022
2. LEIVA RA, Bergersen BM, Finbraten AK, Sandvei PK, et al
   High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway.
   Scand J Gastroenterol. 2022 Sep 5:1-5. doi: 10.1080/00365521.2022.2118555.
   

   >> Share

   
   June 2021
3. WALDENSTROM J, Hellstrand K, Westin J, Nilsson S, et al
   Presence of interferon-lambda 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
   Scand J Gastroenterol. 2021 Jun 2:1-6. doi: 10.1080/00365521.2021.1922750.
   

   >> Share

   
   May 2021
4. WALDENSTROM J, Kaberg M, Alanko Blome M, Widell A, et al
   Absence of interferon-lambda 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
   Scand J Gastroenterol. 2021 May 25:1-7. doi: 10.1080/00365521.2021.1925956.
   

   >> Share

   
   
5. PIECHA F, Ganssler JM, Ozga AK, Wehmeyer MH, et al
   Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era.
   Scand J Gastroenterol. 2021 May 19:1-9. doi: 10.1080/00365521.2021.1915374.
   

   >> Share

   
   March 2021
6. STOY S, Terczynska-Dyla E, Veidal SS, Rigbolt K, et al
   Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
   Scand J Gastroenterol. 2021;56:304-311.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share